Double blind cross-over study comparing prazosin and methyldopa in the treatment of mild hypertension.
D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001786:Blood Glucose; D001794:Blood Pressure / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D004341:Drug Evaluation; D004562:Electrocardiography; D005260:Female; D005654:Fundus Oculi; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D008750:Methyldopa / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D011799:Quinazolines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D012083:Renin / Q000097:blood
D000959:Antihypertensive Agents; D001786:Blood Glucose; D008738:Methyl Ethers; D010879:Piperazines; D011799:Quinazolines; D008750:Methyldopa; D002784:Cholesterol; D003404:Creatinine; D012083:Renin